Leading UK-based pharmaceutical company achieves 300% improvement in COVID-19 screening process using high-end data and process integration solution

Rapid COVID-19 screening and accurate verification facilities are critical to safeguard employees and ensure business continuity at pharmaceutical manufacturing units. Virtusa’s automated screening solution helped one of the largest pharma companies to respond quicker to the crisis while enabling continuity to drug manufacturing.

When the potential magnitude of the COVID-19 pandemic became clear in early 2020, pharmaceutical manufacturers around the globe started exploring ways to curb its impact on daily operations.

For our client, one of the largest pharmaceutical companies, manufacturing facilities and the supply chain have been actively engaged in production of medicines even during lockdowns. To enable the R&D unit to function without hiccups and meet business objectives, the client wanted a scalable and efficient screening system to accelerate the screening process for frontline and other medical staff and overcome disruption in operations.

Virtusa partnered with the client to implement a reliable and automated screening system that fast-tracked regular COVID-19 testing for critical employees entering a production site. The solution ensured compliance, improved detection accuracy, and increased security and compliance with government mandates. Our solution helped improve the end-to-end screening time by 300% and ensured seamless operation at the manufacturing sites.